As immune complex activation of neutrophils promotes tissue injury in several autoimmune diseases, including experimental EBA (Koga et al., 2019; Ludwig et al., 2017), we next investigated if anti‐FcRn changes neutrophil CD62L expression in EBA‐affected mice. This evidence concerns the gene SELL and autoimmune disease.